
Cyclosporine: A strong oral immune-suppressing drug used in short bursts for severe eczema and psoriasis. It works faster than anything else, and blood pressure and kidney function set a hard limit on how long anyone stays on it. Protopic: A non-steroid ointment for eczema, used where steroids are hardest to keep using: the face, the eyelids, and skin folds. It carries a boxed warning that twenty years of follow-up have not supported.


Choose for a fast, short burst of control in severe eczema or psoriasis while a longer-term treatment is set up.
Choose for eczema where steroids are hardest to keep using — face, eyelids, folds — or to prevent flares twice a week.
Can you take them together?
Protopic can be used on the face or folds during a cyclosporine course. Very little Protopic reaches the blood.
Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.












Inhibits calcineurin: Binds cyclophilin to block a T-cell activation switch. Reduces IL-2 signals: Limits a messenger that helps T cells become active. Calms skin inflammation: Overactive immune responses in skin decrease.
Cyclosporine binds cyclophilin; that complex inhibits calcineurin and T-cell cytokine production. This is a simplified skin-focused explanation of systemic immunosuppression.

Inhibits calcineurin: Blocks a switch that helps activate T cells. Reduces immune messengers: T cells release fewer inflammation-driving signals. Calms eczema and itch: Redness and irritation ease as inflammation settles.
The drug binds FKBP-12 and inhibits calcineurin, reducing T-cell cytokine transcription; the complete atopic-dermatitis mechanism is not known. It also has other cellular effects.
The dose is set by body weight, then adjusted by blood pressure and kidney tests, not by how the skin looks.
Starting dose: About 2.5 mg per kilogram of body weight a day, split into two doses. A severe flare may start around 4 to 5 mg per kilogram a day to get control quickly.
Going up: Raised in small steps every two to four weeks if response is poor, and only if the tests are stable.
Coming down: Once the skin is calm, the dose comes down in stages, to give the next treatment time to work.
Total course: Short by design. Many courses run 8 to 16 weeks. Guidelines advise no more than about a year of continuous treatment, less where possible.
When to Apply: A thin layer twice a day to the affected skin, rubbed in gently. It goes on the rash, not over clear skin. Keep moisturizer a couple of hours apart — layering one straight onto the other has not been studied.
How to Start: Twice a day until the patch clears, usually one to three weeks, then stop. Many people then move to maintenance — twice a week on the places that always flare, even when they look normal. That is well supported and makes flares less frequent.
If It Irritates: Burning or stinging for fifteen to thirty minutes after applying is very common in the first days and is not an allergy. It settles within about a week. Keeping the tube in the fridge, applying to dry rather than damp skin, and skipping alcohol early on all help.
If It's Not Working: Check it is going on twice a day — two to three weeks is a fair trial. Then the options are the higher strength if you are an adult on 0.03%, a short steroid course to break the flare, or a look at whether infection or a contact allergy is driving the rash.
Twice a day, about 12 hours apart, at the same times daily. Be consistent about food: always with meals or always without, because switching changes absorption. Swallow capsules whole and leave them in the foil until you take them.
On the liquid, mix it with orange or apple juice in a glass cup, stir and drink it straight away, then rinse the cup with more juice and drink that too. Never use grapefruit juice.
Take it when you remember unless the next dose is close, then skip it. Never take two at once. Tell the prescriber if you miss more than a dose or two, or vomit soon after taking it, because the dose is built around your blood level.
Cyclosporine is monitored more closely than any other skin drug, and that monitoring is why it can be used at all. Blood pressure is measured at every visit, often at home. Kidney function is checked by blood test, twice before starting for a reliable baseline, then every couple of weeks for a month or two, then monthly once the dose is steady. The same draws cover potassium, magnesium, uric acid, liver enzymes, blood counts and cholesterol. Drug blood levels are routine in transplant care, not usually needed at dermatology doses.
Two numbers drive the decisions. A rise in creatinine of about a quarter above your baseline, confirmed on a repeat test, means dropping the dose; about half means stopping. New high blood pressure means lowering the dose or adding a blood pressure medicine, and the choice matters: diltiazem and verapamil push levels up, amlodipine does not.
The interaction list is long. Drugs that raise levels include the azole antifungals, clarithromycin and erythromycin, and some HIV and hepatitis C medicines. Drugs that lower it include rifampin, phenytoin, carbamazepine and St John's wort. It also raises statin levels, so that dose is often reduced, and it interacts with colchicine, digoxin, methotrexate and potassium-sparing water tablets. Bring every prescription, supplement and herbal product to the first visit.
The time limit is the point of all this. Kidney damage builds with continuous use and part of it can be permanent, so guidelines cap continuous treatment at about a year and most dermatology courses are far shorter. Long or repeated use also raises the risk of skin cancer, lymphoma and serious infection, so skin checks continue afterward.
No blood tests are needed. Blood levels are usually undetectable with the ointment and fall further as the barrier repairs — the opposite of the oral form used after transplants. Monitoring is a check at two to three weeks on whether the rash responded, then a plan for maintenance.
The boxed warning is the part to understand. It says long-term safety is not established, that rare cases of lymphoma and skin cancer were reported in people who used these drugs, and that continuous long-term use should be avoided. It was added in 2006, based mainly on animal studies using very high doses by mouth or injection, plus scattered case reports.
What has happened since matters. Large cohort studies, and a registry that followed treated children for a decade, have not found the rise in lymphoma the warning describes. Guidelines in the United States and Europe still recommend these drugs, including on the face and eyelids and as twice-weekly maintenance. The concern was theoretical, more than twenty years of use has not borne it out, and how long to continue is still a decision to make with a doctor.
Day-to-day monitoring is simple: keep skin checks routine, use sun protection on treated areas, and pause during a skin infection.
Approximate windows, not promises.
First 2 weeksStarting: Itch settles first, often within days, and sleep improves. Tingling or burning in the hands and feet, headache and mild nausea are common early. Blood pressure and kidney tests get checked.
Weeks 2 to 6Working: Redness, weeping and thickness improve clearly. Chronic hives that antihistamines do not control usually settle within a month. Extra hair growth on the face, arms and body and swollen or tender gums start now; both are dose-related and reverse after stopping.
Weeks 8 to 16Plaque psoriasis: Large improvement, often near-clear at the higher end of the dose range. Usually where the course ends and another treatment takes over.
VariableSevere inflammatory ulcers: In pyoderma gangrenosum it stops the ulcer spreading while healing catches up. Response times differ a lot.
ThroughoutThe tests: Blood pressure creeping up and kidney numbers drifting decide whether the dose drops or the drug stops. Neither causes symptoms, which is why the tests are not optional.
First few minutesApplying it: A thin layer twice a day. Burning or stinging for a short while afterward is common and worst in the first week.
Days 1 to 7Adjusting: Burning is at its worst now. Itch often improves in the same week, which is what gets most people through.
Weeks 1 to 3Working: Redness and thickening settle and the burning has usually stopped. Most people reach their best result here.
MaintenanceKeeping flares apart: Once clear, twice-weekly use on the trouble spots lengthens the gaps between flares. Licensed, not an improvisation.
Sorted by what to do about them.
Generic capsules are cheap next to biologics, part of why the drug is still used. Branded versions cost more without working better.
The visible cost is not the whole cost. Repeated blood tests, blood pressure checks and appointments add up, and none are optional. It is cheaper per month than a biologic but taken for only a few months, so the comparison depends on what comes after.
Insurance generally covers it for severe psoriasis. Eczema coverage varies more in the United States, where that use is off-label.
Both strengths come as generics, which brought the price down a long way, though it still costs more than a generic steroid ointment. Prices vary widely between pharmacies and discount cards sometimes beat insurance, so check more than one.
Prior authorization is still common, usually asking that a topical steroid was tried first. Tube size is the practical variable: twice-daily use means a small tube treating a child's face lasts far longer than the same tube on two hands.
Faster than anything else for these conditions. Itch improves within days, clearing by four to six weeks.
Most courses run months. Guidelines cap continuous use at about one year, because kidney effects build and some can be permanent.
It raises blood pressure in a meaningful share of people, and that causes no symptoms. Catching it early usually means lowering the dose rather than stopping.
No. Grapefruit, pomelo and Seville oranges block the enzyme that clears it, so levels rise unpredictably. Other citrus is fine.
Both are dose-related. Not dangerous, usually better if the dose comes down, and gone after stopping.
Usually, within weeks to a few months, unless another treatment is running. Planning that before the taper is the point of the short course.
Yes, and it is printed on the label — long-term safety is not established, and rare cases were reported. Studies following large groups for years have not found the increased risk. A caution, not a demonstrated harm.
It acts on nerve endings in inflamed skin as well as on immune cells. Burning is worst in the first few days and gone within a week as the rash heals.
Yes — eyelid eczema is one of the main reasons it gets prescribed. Keep it off the eye itself and the lid margin.
Alcohol flushing is a known effect while using it. Harmless, and it stops when the treatment does.
The label asks for the shortest suitable use and for breaks. Twice-weekly maintenance on trouble spots is licensed and widely used. Make that decision with a doctor rather than leaving a prescription running.
No. Blood levels are usually undetectable with the ointment. The tablets are a different treatment entirely.